LMR Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
LMR Partners's LLY Position: Q3 2026 in Review
LMR Partners reduced its Eli Lilly (LLY) stake by 83% in Q3 2026, selling an estimated $3.3M and leaving 590 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.
LMR Partners first reported a position in LLY in Q2 2015 and has held it in 25 quarters since. The position peaked at $86M in Q1 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- LMR Partners held 590 shares of Eli Lilly worth $683K as of Q3 2026.
- LMR Partners sold 2,800 Eli Lilly shares in Q3 2026, an estimated $3.3M.
- Eli Lilly made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1166 holding.
- LMR Partners first reported a position in Eli Lilly in Q2 2015 and has held it in 25 quarters since.
- LMR Partners's Eli Lilly position peaked at $86M in Q1 2026.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.